Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04214873 · ClinicalTrials.gov registry record · NA
Evaluation of the Effectiveness of the PiQo4 System for Reduction of Infra-orbital Pigmentation
A NA study, sponsored by Focus Medical.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT04214873: Completed NA study, sponsored by Focus Medical.
NCT04214873 is a NA study that has completed, run by Focus Medical. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04214873, a NA study, has completed, sponsored by Focus Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
A total of 10 healthy subjects at a single site, aged 18-65 years old and Fitzpatrick skin type I-IV with mild to moderate infra-orbital hyperpigmentation on the background of epidermal and/or dermal pigmentation that wish to improve their POH
Primary Outcome
POH improvement of at least 1 point evaluated by the investigator at the 3-month follow up compared to baseline using the POH severity in comparison to surrounding skin scale where score of between 0 and 4 will be assigned (0-Normal (Skin color comparable to other facial skin areas); 1- Trace (Faint pigmentation of infraorbital fold (bilateral)); 2- Mild (Pigmentation more pronounced); 3- Moderate (Deep dark colour, all four lids involved): ; 4 - Marked (Grade 3 + pigmentation spreading beyond i
Interventions
- DEVICE PiQo4 Laser System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-01-06 |
| Est. Completion | 2022-01-20 |
| Phase | NA |
What the finished NCT04214873 record still lists
NCT04214873 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which PiQo4 Laser System is the first listed.
NCT04214873 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04214873 about?
NCT04214873 is a clinical study titled "Evaluation of the Effectiveness of the PiQo4 System for Reduction of Infra-orbital Pigmentation". A total of 10 healthy subjects at a single site, aged 18-65 years old and Fitzpatrick skin type I-IV with mild to moderate infra-orbital hyperpigmentation on the background of epidermal and/or dermal pigmentation that wish to improve their POH
What is the current status of trial NCT04214873?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2020-01-06. Estimated completion is 2022-01-20.
What interventions are being tested in trial NCT04214873?
The interventions under investigation include: PiQo4 Laser System (DEVICE).
Who is sponsoring clinical trial NCT04214873?
This trial is sponsored by Focus Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04214873's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI